Study on the Peristaltic Direction of GI Anastomosis in Roux-en-Y Reconstruction

  • STATUS
    Recruiting
  • End date
    Mar 31, 2024
  • participants needed
    148
  • sponsor
    Tianjin Medical University Cancer Institute and Hospital
Updated on 10 April 2022
gastrectomy
lymphadenectomy
adenocarcinoma

Summary

The aim of this study is intending to provide the optimal procedures of the peristaltic direction of gastrointestinal anastomosis in Roux-en-Y reconstruction after distal curative gastrectomy for gastric cancer, which can provide the best operation mode of Roux-en-Y anastomosis in digestive tract reconstruction during distal gastrectomy for reducing postoperative complications and improving quality of life for patients.

Description

In this study, all 148 the included patients will underwent the distal curative gastrectomy for gastric cancer and will be performed the Roux-en-Y reconstruction for gastrointestinal anastomosis. Of them, 74 patients will be randomized in the group undergoing with the isoperistaltic anastomosis in the Roux-en-Y reconstruction procedure. Meanwhile, the other 74 cases will be randomized in the group undergoing with the antiperistaltic anastomosis in the Roux-en-Y reconstruction procedure. Then, we will evaluate the differencies of effects of early recovery postoperatively (exhaust, defecation, eating, residual stomach peristalsis, length of hospital stay, etc.) and late gastrointestinal effects (bile reflux, residual gastritis, gastric emptying function, etc.) between above two group of patients, which will make an important contribution to reduce medical costs and potential improvements of the prognosis after distal curative gastrectomy for gastric cancer.

Details
Condition Peristaltic Direction, Roux-en-Y Gastrointestinal Anastomosis, Gastric Cancer
Treatment Direction procedure of gastrointestinal anastomosis in Roux-en-Y reconstruction
Clinical Study IdentifierNCT04801459
SponsorTianjin Medical University Cancer Institute and Hospital
Last Modified on10 April 2022

Eligibility

Yes No Not Sure

Inclusion Criteria

) Pathological examination confirmation the adenocarcinoma of stomach before surgery
) Physical conditions compliance with the requirements for curative gastrectomy
) Consent to undergo the D2 lymphadenectomy, and the dissected proportion of stomach no less than 2/3
) Comply with the protocol during the whole study period
) No neoadjuvant therapy administration
) Sign informed consent and permission of withdraw in the whole study period
) Consent to provide the tissue specimens after surgery for this study
) Estimation the overall survival after surgery no less than 6 months
) No anesthesia or operation contraindication disease
) cT1-4N0-2M0 stage demonstration by CT and endoscopic ultrasonography examinations
) Negative cytological detection in operation
) No seriously concomitance's diseases
) Karnofsky Performance Scores (KPS) more than 60
) Examined lymph node count no less than 16

Exclusion Criteria

) Women during pregnant stage and breast-feed stage
) Women of childbearing age without any contraceptive measures
) Severe congestive heart failure, frequent arrhythmia, or myocardial infarction within 12 months
) Immunosuppressive therapists for organ transplantation
) Seriously uncontrolled recurrent infection
) other malignant tumors
) No abilities of self-knowledge or mental disorders
) Participating in other clinical trials
) Siewert I and II esophagogastric junction tumors
) Serious internal diseases obstruction surgery
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note